Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Clinical presentation of prostate cancer in black South Africans.

Tindall EA, Monare LR, Petersen DC, van Zyl S, Hardie RA, Segone AM, Venter PA, Bornman MS, Hayes VM.

Prostate. 2014 Jun;74(8):880-91. doi: 10.1002/pros.22806. Epub 2014 Apr 9.

2.

Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa.

Tindall EA, Bornman MS, van Zyl S, Segone AM, Monare LR, Venter PA, Hayes VM.

BMC Urol. 2013 Dec 29;13:74. doi: 10.1186/1471-2490-13-74.

3.

Complex patterns of genomic admixture within southern Africa.

Petersen DC, Libiger O, Tindall EA, Hardie RA, Hannick LI, Glashoff RH, Mukerji M; Indian Genome Variation Consortium, Fernandez P, Haacke W, Schork NJ, Hayes VM.

PLoS Genet. 2013;9(3):e1003309. doi: 10.1371/journal.pgen.1003309. Epub 2013 Mar 14.

4.

A novel SERPINA1 mutation causing serum alpha(1)-antitrypsin deficiency.

Saunders DN, Tindall EA, Shearer RF, Roberson J, Decker A, Wilson JA, Hayes VM.

PLoS One. 2012;7(12):e51762. doi: 10.1371/journal.pone.0051762. Epub 2012 Dec 12.

5.

Interleukin-6 promoter variants, prostate cancer risk, and survival.

Tindall EA, Severi G, Hoang HN, Southey MC, English DR, Hopper JL, Giles GG, Hayes VM; Australian Prostate Cancer BioResource.

Prostate. 2012 Dec 1;72(16):1701-7. doi: 10.1002/pros.22557. Epub 2012 Jul 10.

PMID:
22782910
6.

Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).

Miller W, Hayes VM, Ratan A, Petersen DC, Wittekindt NE, Miller J, Walenz B, Knight J, Qi J, Zhao F, Wang Q, Bedoya-Reina OC, Katiyar N, Tomsho LP, Kasson LM, Hardie RA, Woodbridge P, Tindall EA, Bertelsen MF, Dixon D, Pyecroft S, Helgen KM, Lesk AM, Pringle TH, Patterson N, Zhang Y, Kreiss A, Woods GM, Jones ME, Schuster SC.

Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12348-53. doi: 10.1073/pnas.1102838108. Epub 2011 Jun 27. Erratum in: Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18625.

7.

Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.

Tindall EA, Severi G, Hoang HN, Ma CS, Fernandez P, Southey MC, English DR, Hopper JL, Heyns CF, Tangye SG, Giles GG, Hayes VM; Australian Prostate Cancer BioResource.

Carcinogenesis. 2010 Oct;31(10):1748-54. doi: 10.1093/carcin/bgq081. Epub 2010 Apr 19.

PMID:
20403914
8.

The 4q27 locus and prostate cancer risk.

Tindall EA, Hoang HN, Southey MC, English DR, Hopper JL, Giles GG, Severi G, Hayes VM.

BMC Cancer. 2010 Feb 25;10:69. doi: 10.1186/1471-2407-10-69.

9.

Interpretation of custom designed Illumina genotype cluster plots for targeted association studies and next-generation sequence validation.

Tindall EA, Petersen DC, Nikolaysen S, Miller W, Schuster SC, Hayes VM.

BMC Res Notes. 2010 Feb 22;3:39. doi: 10.1186/1756-0500-3-39.

10.

Complete Khoisan and Bantu genomes from southern Africa.

Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, Kasson LR, Harris RS, Petersen DC, Zhao F, Qi J, Alkan C, Kidd JM, Sun Y, Drautz DI, Bouffard P, Muzny DM, Reid JG, Nazareth LV, Wang Q, Burhans R, Riemer C, Wittekindt NE, Moorjani P, Tindall EA, Danko CG, Teo WS, Buboltz AM, Zhang Z, Ma Q, Oosthuysen A, Steenkamp AW, Oostuisen H, Venter P, Gajewski J, Zhang Y, Pugh BF, Makova KD, Nekrutenko A, Mardis ER, Patterson N, Pringle TH, Chiaromonte F, Mullikin JC, Eichler EE, Hardison RC, Gibbs RA, Harkins TT, Hayes VM.

Nature. 2010 Feb 18;463(7283):943-7. doi: 10.1038/nature08795.

11.

Comprehensive sequence analysis of the human IL23A gene defines new variation content and high rate of evolutionary conservation.

Tindall EA, Hayes VM.

DNA Res. 2010 Apr;17(2):117-22. doi: 10.1093/dnares/dsq003. Epub 2010 Feb 12.

12.

Inflammatory genetic markers of prostate cancer risk.

Tindall EA, Hayes VM, Petersen DC.

Cancers (Basel). 2010 Jun 8;2(2):1198-220. doi: 10.3390/cancers2021198.

13.

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.

Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE.

Clin Cancer Res. 2009 Sep 1;15(17):5338-49. doi: 10.1158/1078-0432.CCR-08-2865. Epub 2009 Aug 25.

14.

Assessing high-resolution melt curve analysis for accurate detection of gene variants in complex DNA fragments.

Tindall EA, Petersen DC, Woodbridge P, Schipany K, Hayes VM.

Hum Mutat. 2009 Jun;30(6):876-83. doi: 10.1002/humu.20919.

PMID:
19280649
15.

Novel Plexor SNP genotyping technology: comparisons with TaqMan and homogenous MassEXTEND MALDI-TOF mass spectrometry.

Tindall EA, Speight G, Petersen DC, Padilla EJ, Hayes VM.

Hum Mutat. 2007 Sep;28(9):922-7.

PMID:
17458878
16.

Yesterday, today, and tomorrow.

Tindall EA.

Arthritis Rheum. 2006 Apr;54(4):1029-33. No abstract available.

17.

Treatment for rheumatic disorders.

Tindall EA, Fox DA.

N Engl J Med. 2006 Mar 23;354(12):1322-3. No abstract available.

18.

Evaluation of health-related quality of life of rheumatoid arthritis patients treated with celecoxib.

Zhao SZ, Fiechtner JI, Tindall EA, Dedhiya SD, Zhao WW, Osterhaus JT, Yu SS.

Arthritis Care Res. 2000 Apr;13(2):112-21.

PMID:
14635284
19.

Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.

Fleischmann RM, Baumgartner SW, Tindall EA, Weaver AL, Moreland LW, Schiff MH, Martin RW, Spencer-Green GT.

J Rheumatol. 2003 Apr;30(4):691-6.

PMID:
12672185
20.

A 12-month, multicenter, prospective, open-label trial of radiographic analysis of disease progression in osteoarthritis of the knee or hip in patients receiving celecoxib.

Tindall EA, Sharp JT, Burr A, Katz TK, Wallemark CB, Verburg K, Lefkowith JB.

Clin Ther. 2002 Dec;24(12):2051-63.

PMID:
12581544
21.

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Bulpitt K, Martin R, Weinblatt M, Taborn J, Weaver A, Burge DJ, Schiff MH.

J Rheumatol. 2001 Jun;28(6):1238-44.

PMID:
11409115
22.

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.

Ann Intern Med. 1999 Mar 16;130(6):478-86.

PMID:
10075615
23.

Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.

Bocanegra TS, Weaver AL, Tindall EA, Sikes DH, Ball JA, Wallemark CB, Geis GS, Fort JG.

J Rheumatol. 1998 Aug;25(8):1602-11.

PMID:
9712107
24.

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, Ettlinger RE, Cohen S, Koopman WJ, Mohler K, Widmer MB, Blosch CM.

N Engl J Med. 1997 Jul 17;337(3):141-7.

25.

Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.

Raskin JB, White RH, Jackson JE, Weaver AL, Tindall EA, Lies RB, Stanton DS.

Ann Intern Med. 1995 Sep 1;123(5):344-50.

PMID:
7625622
26.

A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.

Roth SH, Tindall EA, Jain AK, McMahon FG, April PA, Bockow BI, Cohen SB, Fleischmann RM.

Arch Intern Med. 1993 Nov 22;153(22):2565-71.

PMID:
8239849
27.

Clinical characteristics of fibrositis. II. A "blinded," controlled study using standard psychological tests.

Clark S, Campbell SM, Forehand ME, Tindall EA, Bennett RM.

Arthritis Rheum. 1985 Feb;28(2):132-7.

PMID:
3882093
28.

Gonococcal osteomyelitis complicating septic arthritis.

Tindall EA, Regan-Smith MG.

JAMA. 1983 Nov 18;250(19):2671-3. No abstract available.

PMID:
6415302
29.

Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points.

Campbell SM, Clark S, Tindall EA, Forehand ME, Bennett RM.

Arthritis Rheum. 1983 Jul;26(7):817-24.

PMID:
6347207

Supplemental Content

Loading ...
Support Center